SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000078003-21-000093
Filing Date
2021-08-12
Accepted
2021-08-12 16:01:31
Documents
92
Period of Report
2021-07-04

Document Format Files

Seq Description Document Type Size
1 10-Q pfe-20210704.htm   iXBRL 10-Q 4216061
2 EX-31.1 pfe-exh311x0704202110q.htm EX-31.1 9176
3 EX-31.2 pfe-exh312x0704202110q.htm EX-31.2 9195
4 EX-32.1 pfe-exh321x0704202110q.htm EX-32.1 4616
5 EX-32.2 pfe-exh322x0704202110q.htm EX-32.2 4620
  Complete submission text file 0000078003-21-000093.txt   17501429

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pfe-20210704.xsd EX-101.SCH 87301
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pfe-20210704_cal.xml EX-101.CAL 170608
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pfe-20210704_def.xml EX-101.DEF 409390
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pfe-20210704_lab.xml EX-101.LAB 944556
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pfe-20210704_pre.xml EX-101.PRE 623782
11 EXTRACTED XBRL INSTANCE DOCUMENT pfe-20210704_htm.xml XML 4698001
Mailing Address 235 E 42ND ST NEW YORK NY 10017
Business Address 235 E 42ND ST NEW YORK NY 10017 2125732323
PFIZER INC (Filer) CIK: 0000078003 (see all company filings)

IRS No.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-03619 | Film No.: 211167382
SIC: 2834 Pharmaceutical Preparations